APA (7th ed.) Citation

Man, X., Huang, J., Sun, S., Zhou, D., Zhang, B., Fang, S., . . . Li, H. (2024). Efficacy and safety of pyrotinib combined with albumin‐bound paclitaxel as first‐line treatment for HER2‐positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy. Clinical and Translational Medicine, 14(5), . https://doi.org/10.1002/ctm2.1687

Chicago Style (17th ed.) Citation

Man, Xiaochu, et al. "Efficacy and Safety of Pyrotinib Combined with Albumin‐bound Paclitaxel as First‐line Treatment for HER2‐positive Metastatic Breast Cancer in Patients Previously Treated with Adjuvant And/or Neoadjuvant Trastuzumab Therapy." Clinical and Translational Medicine 14, no. 5 (2024). https://doi.org/10.1002/ctm2.1687.

MLA (9th ed.) Citation

Man, Xiaochu, et al. "Efficacy and Safety of Pyrotinib Combined with Albumin‐bound Paclitaxel as First‐line Treatment for HER2‐positive Metastatic Breast Cancer in Patients Previously Treated with Adjuvant And/or Neoadjuvant Trastuzumab Therapy." Clinical and Translational Medicine, vol. 14, no. 5, 2024, https://doi.org/10.1002/ctm2.1687.